Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa

Clinical and Experimental Immunology

Volumn 122, Issue 1, 2000, Pages 67-71

  Yanagihara, K ^a   Tomono, K ^a   Kuroki, M ^a   Kaneko, Y ^a   Sawai, T ^a   Ohno, H ^a   Miyazaki, Y ^a   Higashiyama, Y ^a   Maesaki, S ^a   Kadota, J I ^a   Kohno, S ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Anti TNF antibody; Chronic respiratory infection; Inflammatory cytokines; Macrolide antibiotics; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MACROLIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CHRONIC DISEASE; CONTROLLED STUDY; EXPERIMENTAL MODEL; GRAM NEGATIVE INFECTION; INFLAMMATION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BRONCHIOLITIS; CLARITHROMYCIN; CYTOKINES; DISEASE MODELS, ANIMAL; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; MALE; MICE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TISSUE EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033771564     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01343.x     Document Type: Article

References (23)

1. Diffuse panbronchiolitis. A disease of the transitional zone of the lung
2. Study of bronchus-associated lymphoid tissue in patients with diffuse panbronchiolitis
3. Clinical effect of low-dose and long-term erythromycin chemotherapy on diffuse panbronchiolitis
4. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis
5. Increase of activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis
6. Interleukin-1 beta, tumor necrosis factor-α and interleukin-8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: Potential mechanism of macrolide therapy
7. Inhibitory effect of erythromycin on interleukin-8 production by 1alpha, 25-dihydroxyvitamin D3-stimulated THP-1 cells
8. Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection
9. Purification and characterization of intraparenchymal lung lymphocytes
10. Antiasthmatic activity of a macrolide antibiotic, Roxythromycin: Analysis of possible mechanisms in vitro and in vivo
11. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
12. Eosinophilic activation in cystic fibrosis
13. Vaccination promotes Th1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats
14. Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response
15. Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia
16. Role of tumor necrosis factor α in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa
17. Recombinant cytokines and pulmonary host defense
18. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs
19. Requirement of tumor necrosis factor-α for development of silica-induced pulmonary fibrosis
20. Tumor necrosis factor-α: A pleiotropic cytokine and therapeutic target
21. Antibodies to cachectin/tumor necrosis factor-α reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia
22. Inflammatory cytokines in cystic fibrosis lungs
23. Microbial pathogenesis in cystic fibrosis: Pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge